Legend Interest Expense from 2010 to 2023
LEGN Stock | USD 60.82 1.00 1.67% |
Legend BiotechCorp Quarterly Interest Expense |
|
Check Legend BiotechCorp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Legend main balance sheet or income statement drivers, such as Cost of Revenue of 58.5 M, Gross Profit of 62.4 M or Interest Expense of 11.6 M, as well as many exotic indicators such as Asset Turnover of 0.1, Book Value per Share of 4.09 or Current Ratio of 3.7. Legend financial statements analysis is a perfect complement when working with Legend BiotechCorp Valuation or Volatility modules.
Legend | Interest Expense |
Legend Interest Expense Breakdown
Showing smoothed Interest Expense of Legend BiotechCorp with missing and latest data points interpolated. Amount of the cost of borrowed funds accounted for as interest expense. Where this item is not contained on the company consolidated financial statements and cannot otherwise be imputed the value of 0 is used. Legend BiotechCorp's Interest Expense historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Legend BiotechCorp's overall financial position and show how it may be relating to other accounts over time.
Interest Expense | 10 Years Trend |
|
Interest Expense |
Timeline |
Legend Interest Expense Regression Statistics
Arithmetic Mean | 2,036,737 | |
Geometric Mean | 279,557 | |
Coefficient Of Variation | 198.64 | |
Mean Deviation | 2,934,729 | |
Median | 82,000 | |
Standard Deviation | 4,045,859 | |
Range | 11,566,316 | |
R-Value | 0.69 | |
R-Squared | 0.48 | |
Significance | 0.005949 | |
Slope | 670,708 |
Legend Interest Expense History
About Legend BiotechCorp Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include Legend BiotechCorp income statement, its balance sheet, and the statement of cash flows. Legend BiotechCorp investors use historical funamental indicators, such as Legend BiotechCorp's Interest Expense, to determine how well the company is positioned to perform in the future. Although Legend BiotechCorp investors may use each financial statement separately, they are all related. The changes in Legend BiotechCorp's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Legend BiotechCorp's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Legend BiotechCorp Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Legend BiotechCorp. Please read more on our technical analysis and fundamental analysis pages.
Last Reported | Projected for 2023 | ||
Interest Expense | 10.8 M | 11.6 M | |
Earnings Before Interest Taxes and Depreciation Amortization EBITDA | -416.5 M | -427.5 M |
Legend BiotechCorp Investors Sentiment
The influence of Legend BiotechCorp's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Legend. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Legend BiotechCorp's public news can be used to forecast risks associated with an investment in Legend. The trend in average sentiment can be used to explain how an investor holding Legend can time the market purely based on public headlines and social activities around Legend BiotechCorp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Legend BiotechCorp's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Legend BiotechCorp's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Legend BiotechCorp's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Legend BiotechCorp.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Legend BiotechCorp in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Legend BiotechCorp's short interest history, or implied volatility extrapolated from Legend BiotechCorp options trading.
Becoming a Better Investor with Macroaxis
Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Legend BiotechCorp using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.Build Optimal Portfolios
Align your risk with return expectations
Check out the analysis of Legend BiotechCorp Correlation against competitors. To learn how to invest in Legend Stock, please use our How to Invest in Legend BiotechCorp guide.Note that the Legend BiotechCorp information on this page should be used as a complementary analysis to other Legend BiotechCorp's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Legend Stock analysis
When running Legend BiotechCorp's price analysis, check to measure Legend BiotechCorp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Legend BiotechCorp is operating at the current time. Most of Legend BiotechCorp's value examination focuses on studying past and present price action to predict the probability of Legend BiotechCorp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Legend BiotechCorp's price. Additionally, you may evaluate how the addition of Legend BiotechCorp to your portfolios can decrease your overall portfolio volatility.
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |
Is Legend BiotechCorp's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Legend BiotechCorp. If investors know Legend will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Legend BiotechCorp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.96) | Revenue Per Share 1.358 | Quarterly Revenue Growth 2.509 | Return On Assets (0.18) | Return On Equity (0.49) |
The market value of Legend BiotechCorp is measured differently than its book value, which is the value of Legend that is recorded on the company's balance sheet. Investors also form their own opinion of Legend BiotechCorp's value that differs from its market value or its book value, called intrinsic value, which is Legend BiotechCorp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Legend BiotechCorp's market value can be influenced by many factors that don't directly affect Legend BiotechCorp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Legend BiotechCorp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Legend BiotechCorp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Legend BiotechCorp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.